MSB 2.01% $1.52 mesoblast limited

Cell Therapy News/Articles, page-11110

  1. 2,929 Posts.
    lightbulb Created with Sketch. 2059
    Pledge - you just said
    Those that were directly impacted by the FDA not issuing an approval for AGVHD did not rage against the decision. Not one of them.

    Perhaps rage is not the only tactic

    Reg
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.